RSS
TwitterFacebook

Suboxone Used To Treat Opiod Disorder Causes Serious Dental Injuries Featured

Lawsuits claim drug manufacturer, Indivior, knew or should have known the risks that Suboxone poses to dental health but failed to warn medical providers and consumers.

Numerous lawsuits were recently filed alleging Suboxone, a drug used to treat opiod disorder, causes serious tooth decay. The lawsuits claim drug manufacturer, Indivior, knew or should have known the risks but failed to warn medical providers and consumers.

What Dental Injuries Are Being Reported After Using Suboxone?

Dental problems have been reported even in patients with no history of dental issues after using Suboxone including:

  • tooth decay,
  • cavities,
  • dental abscesses/infection,
  • tooth erosion and,
  • total tooth loss.

Indivior Relied On Deceptive Marketing To Boost Sales

The lack of any labeling warning of the risk prompted the FDA in January 2022 to issue its own warning to patients and prescribers about the potential for dental problems associated with Suboxone when dissolved in the mouth to treat opiod use disorder (OUD) and pain.

The FDA forced Indivior, in June 2022, to add a new warning about the risk of dental problems be added to the prescribing information. The patient Medication Guide for Suboxone, however, still does not warn of the risks and side effects.

Prescribers should advise patients to see a dentist soon after starting the medicine and during treatment. Patients should report to the dentist all medicines that they take, including buprenorphine. for all buprenorphine-containing medicines that are dissolved in the mouth.

Prescribers should advise patients to see a dentist soon after starting the medicine and during treatment. Patients should report to the dentist all medicines that they take, including buprenorphine.

Indivior Sought To Limit Suboxone Competition Forcing Consumers To Overpay For the Drug

Prior to  people filing Suboxone lawsuits for dental problems, Indivior and Reckitt Benckiser, Indivior’s former parent company, faced an antitrust Suboxone class-action lawsuit that claimed limited competition caused consumers to overpay for the drug. In 2019 and 2020, the FTC reached settlements totaling $60 million. Consumers received the first payments in May 2021 and the remaining class members received payments in April 2023.

Do I Qualify To Participate In The Suboxone Dental Injuries Case?

If you have had dental problems following use of prescription Suboxone film, you may qualify to participate in the Suboxone Dental Injuries litigation. There is no cost to you.

To learn more or join the case, please complete the form shown below and an experienced product liability lawyer will contact to to discuss your claim.


Tags:        

Leave a Reply

Your email address will not be published. Required fields are marked *